Advanced SearchSearch Tips
Role of certain nutritional supplements and biological regulators in the epilepsy
facebook(new window)  Pirnt(new window) E-mail(new window) Excel Download
  • Journal title : TANG [HUMANITAS MEDICINE]
  • Volume 3, Issue 4,  2013, pp.29.1-29.11
  • Publisher : Association of Humanitas Medicine
  • DOI : 10.5667/tang.2013.0020
 Title & Authors
Role of certain nutritional supplements and biological regulators in the epilepsy
Asif, Mohammad;
  PDF(new window)
Certain dietary contents, biological supplements might influence the occurrence or treatment of epilepsy. Some studies have found that the supplementation with individual nutrients reduced seizure frequency or improved other aspects of health in patients with epilepsy. Potentially beneficial dietary interventions include treating blood glucose dysregulations. Identifying and avoiding allergenic foods, and avoiding suspected triggering agents such as alcohol, aspartame, and monosodium glutamate. The Atkins diet (very low in carbohydrates) is a less restrictive type diet that may be effective in some cases. Nutrients that may reduce seizure frequency include vitamin B6, magnesium, vitamin E, manganese, taurine, dimethylglycine, and omega-3 fatty acids. Administration of thiamine may improve cognitive function in patients with epilepsy. Supplementation with folic acid, vitamin B6, biotin, vitamin D, and L-carnitine may be needed to prevent or treat deficiencies resulting from the use of anticonvulsant drugs. Vitamin K1 has been recommended near the end of pregnancy for women taking anticonvulsants. Melatonin may reduce seizure frequency in some cases, and progesterone may be useful for women with cyclic exacerbations of seizures. In most cases, nutritional therapy is not a substitute for anticonvulsant medications. However, in selected cases, depending on the effectiveness of the interventions, dosage reductions or discontinuation of medications may be possible. However, nutrient supplementation may be necessary to prevent or reverse the effects of certain deficiencies that frequently result from the use of antiepileptic drugs.
 Cited by
AfZal S, Kalra G, Kazmi SH, Siddiqui MA. A study of serum and cerebrospinal fluid magnesium in convulsive disorders. J Assoc Physicians. 1985;33:161-163.

Anderson GD. Pharmacogenetics and enzyme induction/inhibition properties of antiepileptic drugs. Neurology.2004;63:S3-S8.

Asadi-Pooya AA, Ghafari A. Do patients with epilepsy believe they need specific dietary restrictions? Epilepsy Behav, 2004;5:945-948. crossref(new window)

Asadi-Pooya AA, Ghetmiri E. Allergy and idiopathic generalized epilepsy: a case-control study. J Pediatr Neurol. 2007;5:231-232.

Asadi-Pooya AA, Ghetmiri E. Folic acid supplementation reduces the development of some blood cell abnormalities in children receiving carbamazepine. Epilepsy Behav. 2006;8:228-231. crossref(new window)

Asadi-Pooya AA, Hossein-Zade A. What do nurses and physicians think about the need for specific dietary restrictions in the patients with epilepsy? Epilepsy Behav. 2005;6:604-606. crossref(new window)

Asadi-Pooya AA, Mintzer S, Sperling MR. Nutritional supplements, foods, and epilepsy Is there a relationship? Epilepsia. 2008;49:1819-1827. crossref(new window)

Asadi-Pooya AA, Sperling MR. Do foods precipitate seizures? A cross-cultural comparison. Epilepsy Behav. 2007;11:450-453. crossref(new window)

Asadi-Pooya AA. Risk factors for carbamazepine-induced leucopenia in children and adolescents. J Pediatr Neurol. 2005;3:233-235.

Auer RN. Can eliminating monosodium glutamate from the diet affect Lennox-Gastaut syndrome? J Am Diet Assoc. 1998;98:857.

Bankier A, Turner M, Hopkins IJ. Pyridoxine dependent selzures-a wider clinical spectrum. Arch Dis Child. 1983;58:415-418. crossref(new window)

Barbeau A, Donaldson J. Zinc, taurine, and epilepsy. Arch Neurol. 1974;30:52-58. crossref(new window)

Bennett CL, Huynh HM, Chance PF, Glass lA, Gospe SM Jr. Genetic heterogeneity for autosomal recessive pyridoxine-dependent seizures. Neurogenetics. 2005;6:143-149. crossref(new window)

Bergamini L, Mutani R, Delsedime M, Durelli L. First clinical experience on the antiepileptic action of taurine. Eur Neurol. 1974;11:261-269. crossref(new window)

Berry-Kravis E, Booth G, Taylor A, Valentino LA. Bruising and the ketogenic diet: evidence for dietinduced changes in platelet function. Ann Neurol. 2001;49:98-103. crossref(new window)

Bhagavan HN, Coursin DB, Stewart CN. Monosodium glutamate induces convulsive disorders in rats. Nature. 1971;232:275-276. crossref(new window)

Bonilha L, Li LM. Heavy coffee drinking and epilepsy. Seizure. 2004;13:284-285. crossref(new window)

Borges LF, Gucer G. Effect of magnesium on epileptic foci. Epilepsia. 1978;19:81-91.

Botez MI, Botez T, Ross-Chouinard A, Lalonde R. Thiamine and folate treatment of chronic epileptic patients: a controlled study with the Wechsler IQ scale. Epilepsy Res. 1993;16:157-163. crossref(new window)

Brown RS, Di Stanislao PT, Beaver WT, Bottomley WK. The administration of folic acid to institutionalized epileptic adults with phenytoininduced gingival hyperplasia. A double-blind, randomized, placebo-controlled, parallel study. Oral Surg Oral Med Oral Pathol. 1991;71:565-568. crossref(new window)

Camfield PR, Camfield CS, Dooley JM, Gordon K, Jollymore S, Weaver DF. Aspartame exacerbates EEG spike-wave discharge in children with generalized absence epilepsy: a double-blind controlled study. Neurology. 1992;42:1000-1003. crossref(new window)

Carl GF, Keen CL, Gallagher BB, Clegg MS, Littleton WH, Flannery DB, Hurley LS. Association of low blood manganese concentrations with epilepsy. Neurology. 1986;36:1584-1587. crossref(new window)

Castaneda GY, Heilbroner PL, Shah N, Forem S, Fish I. Asthma and epilepsy: are they related? A retrospective study. J Child Neurol. 1988;13:283-285.

Ch'ien LT, Krurndieck CL, Scott CW Jr, Butterworth CE Jr. Harmful effect of megadoses of vitamins: electroencephalogram abnormalities and seizures induced by intravenous folate in drug-treated epileptics. Am J Clin Nutr. 1975;28:51-58.

Chou DT, Forde JH, Hirsh KR. Unit activity in medial thalamus: comparative effects of caffeine an amphetamine. J Pharmacol Exp Ther. 1980;213:580-585.

Christiansen C, Rodbro P, Lund M. Incidence of anticonvulsant osteomalacia and effect of vitamin D: controlled therapeutic trial. Br Med J. 1973;4:695-701. crossref(new window)

Christiansen C, Rodbro P, Sjo O. "Anticonvulsant action" of vitamin D in epileptic patients? A controlled pilot study. Br Med J. 1974;2:258-259. crossref(new window)

Clarke TA, Saunders BS, Feldman B. Pyridoxine-dependent seizures requiring high doses of pyridoxine for control. Am J Dis Child. 1979;133:963-965.

Coker SB. Postneonatal vitamin B6-dependent epilepsy. Pediatrics. 1992;90:221-223.

Cornelissen M, Steegers-Theunissen R, Kollee L, Eskes T, Motohara K, Monnens L. Supplementation of vitamin K in pregnant women receiving anticonvulsant therapy prevents neonatal vitamin K deficiency. Am J Obstet Gynecol. 1993;168:884-888. crossref(new window)

Crayton JW, Stone T, Stein G. Epilepsy precipitated by food sensitivity: report of a case with double-blind placebo-controlled assessment. Clin Electroencephalogr. 1981 ;12: 192-198. crossref(new window)

Cronin CC, Jackson LM, Feighery C, Shanahan F, Abuzakouk M, Ryder DQ, Whelton M, Callaghan N. Celiac disease and epilepsy. QJM. 1998;91:303-308. crossref(new window)

Crowell GF, Roach ES. Pyridoxine-dependent seizures. Am Fam Physician. 1983;27:183-187.

Cunningham AS. Allergy, immunodeficiency, and epilepsy. Lancet 1975;2:975.

Davis RE, Reed PA, Smith BK. Serum pyridoxal, folate, and vitamin B12 levels in institutionalized epileptics. Epilepsia. 1975;16:463-468. crossref(new window)

De Lecea A, Ribes-Koninckx C, Polanco I, Calvete JF. Serological screening for non-overt coeliac disease in children of short stature. Acta Paediatr Suppl. 1996;412:54-55.

De Vivo DC, Bohan TP, Coulter DL, Dreifuss FE, Greenwood RS, Nordli DR Jr, Shields WD, Stafstrom CE, Tein I. L-canrntine supplementation in childhood epilepsy: current perspectives. Epilepsia. 1998;39:1216-1225. crossref(new window)

Deb S, Cowie VA, Richens A. Folate metabolism and problem behaviour in mentally handicapped epileptics. J Ment Defic Res. 1987;31:163-168.

Djukic A. Folate-responsive neurologic diseases. Pediatr Neurol. 2007;37:387-397. crossref(new window)

Dupont CL, Tanaka Y. Blood manganese levels in children with convulsive disorder. Biochem Med. 1985;33:246-255. crossref(new window)

Edelstein SF, Chisholm M. Management of intractable childhood seizures using the non-MCT oil ketogenic diet in 20 patients. J Am Diet Assoc. 1996;96:1181-1182. crossref(new window)

Egger J, Carter CM, Soothill JF, Wilson J. Oligoantigenic diet treatment of children with epilepsy and migraine. J Pediatr. 1989;114:51-58. crossref(new window)

Frediani T, Lucarelli S, Pelliccia A, Vagnucci B, Cerminara C, Barbato M, Cardi E. Allergy and childhood epilepsy: a close relationship? Acta Neurol Scand. 2001;104:349-352. crossref(new window)

Freed WJ. Prevention of strychnine-induced seizures and death by the N-methylated glycine derivatives betaine, dimethylglycine and sarcosine. Pharmacol Biochem Behav. 1985;22:641-643. crossref(new window)

Furlanut M, Benetello P, Avogaro A, Dainese R. Effects of folic acid on phenytoin kinetics in healthy subjects. Clin Pharmacol Ther 1978;24:294-297. crossref(new window)

Gaby AR. Natural Approaches to Epilepsy. Altern Med Rev. 2007;12:9-24.

Gaby AR. Magnesium. (New Canaan, USA: Keats Publishing), 1994.

Gaby AR. The Doctor's Guide to Vitamin B6. (Emmaus, USA: Rodale Press), 1984.

Gallagher BB, Prichard JW, Glaser GH. Seizure threshold and excess dietary amino acids. Neurology. 1968;18:208-212. crossref(new window)

Garg SK, Kumar N, Bhargava VK, Prabhakar SK. Effect of grapefruit juice on carbamazepine bioavailability in patients with epilepsy. Clin Pharmacol Ther 1998;64:286-288. crossref(new window)

Gasch AT. Use of the traditional ketogenic diet for treatment of intractable epilepsy. J Am Diet Assoc. 1990;90:1433-1434.

Gascon G, Patterson E, Yearwood K, Slotnick H. N,N dimethylglycine and epilepsy. Epilepsia. 1989;30:90-93. crossref(new window)

Gibberd FB, Nicholls A, Wright MG. The influence of folic acid on the frequency of epileptic attacks. Eur J Clin Pharmacol. 1981;19:57-60. crossref(new window)

Gissel T, Poulsen CS, Vestergaard P. Adverse effects of antiepileptic drugs on bone mineral density in children. Expert Opin Drug Saf 2007;6:267-278. crossref(new window)

Goasduff T, Dreano Y, Guillois B, Menez JF, Berthou F. Induction of liver and kidney CYP1A1/1A2 by caffeine in rat. Biochem Pharmacol. 1996;52:1915-1919. crossref(new window)

Gobbi G, Bouquet F, Greco L, Lambertini A, Tassinari CA, Ventura A, Zaniboni MG. Celiac disease, epilepsy, and cerebral calcifications. The Italian Working Group on Coeliac Disease and Epilepsy. Lancet. 1992;340:439-443. crossref(new window)

Goodman HO, Connolly BM, McLean W, Resnick M. Taurine transport in epilepsy. Clin Chem. 1980;26:414-419.

Gordon N. Medium-chain triglycerides in a ketogenic diet. Dev Med Child Neurol. 1977;19:535-538.

Gospe SM Jr. Pyridoxine-dependent seizures: new genetic and biochemical clues to help with diagnosis and treatment. Curr Opin Neurol. 2006;19: 148-153. crossref(new window)

Goutieres F, Aicardi J. Atypical presentations of pyridoxine-dependent seizures: a treatable cause of intractable epilepsy in infants. Ann Neurol. 1985;17:117-120. crossref(new window)

Grant ECG. Epilepsy and manganese. Lancet. 2004;363:572.

Grant RH, Stores OP. Folic acid in folate-deficient patients with epilepsy. Br Med J. 1970;4:644-648. crossref(new window)

Guidolin L, Vignoli A, Canger R. Worsening in seizure frequency and severity in relation to folic acid administration. Eur J Neurol. 1998;5:301-303. crossref(new window)

Haidukewych D, Rodin EA. N,N-dimethylglycine shows no anticonvulsant potential. Ann Neurol. 1984;15:405. crossref(new window)

Hansson O, Sillanpaa M. Letter: Pyridoxine and serum concentration of phenytoin and phenobarbitone. Lancet. 1976;1:256.

Hemingway C, Freeman JM, Pillas DJ, Pyzik PL. The ketogenic diet: a 3- to 6-year follow-up of 150 children enrolled prospectively. Pediatrics. 2001;108: 898-905. crossref(new window)

Hernandez MA, Colina G, Ortigosa L. Epilepsy, cerebral calcifications and clinical or subclinical celiac disease. Course and follow up with gluten-free diet. Seizure. 1998;7:49-54. crossref(new window)

Herzog AG. Progesterone therapy in women with complex partial and secondary generalized seizures. Neurology. 1995;45:1660-1662. crossref(new window)

Hewitt NJ, Lecluyse EL, Ferguson SS. Induction of hepatic cytochrome P450 enzymes: methods, mechanisms, recommendations, and in vitro-in VIVO correlations. Xenobiotica. 2007;37:1196-1224. crossref(new window)

Hidaka M, Fujita K, Ogikubo T, Yamasaki K, Iwakiri T, Okumura M, Kodama H, Arimori K. Potent inhibition by star fruit of human cytochrome P450 3A (CYP3A) activity. Drug Metab Dispos. 2004;32:581-583. crossref(new window)

Higashi A, Tamari H, Ikeda T, Ohtani Y, Matsukura M, Miyoshino S, Matsuda I. Serum vitamin E concentration in patients with severe multiple handicaps treated with anticonvulsants. Pediatr Pharmacol (New York). 1980;1:129-134.

Hiilesmaa VK, Teramo K, Granstrom ML, Bardy AH. Serum folate concentrations during pregnancy in women with epilepsy: relation to antiepileptic drug concentrations, number of seizures, and fetal outcome. Br Med J (Clin Res ed).1983;287:577-579. crossref(new window)

Holman CP, Bell AF. A trial of evening primrose oil in the treatment of chronic schizophrenia. J Orthomolecular Psychiatry. 1983;12:302-304.

Hom AC, Weaver RC, Alderson JJ. Efficacy of D-alpha tocopherol acetate as adjunctive antiepileptic agent in patients with refractory epilepsy and profound developmental disability: a prospective, randomized, double-blind, placebo-controlled trial. Epilepsia. 1991;32:S62.

Huttenlocher PR, Wilbourn AJ, Signore JM. Mediumchain triglycerides as a therapy for intractable childhood epilepsy. Neurology. 1971;21:1097-1103. crossref(new window)

Johnson GM. Powdered goat's milk: pyridoxine deficiency and status epilepticus. Clin Pediatr (Phila). 1982;21:494-495. crossref(new window)

Jones C, Huyton M, Hindley D. Melatonin and epilepsy. Arch Dis Child. 2005;90:1203.

Joshi S, al-Essa MA, Archibald A, Ozand PT. Biotinidase deficiency: a treatable genetic disorder in the Saudi population. East Mediterr Health J. 1999;5:1213-1217.

Kaufman KR, Sachdeo RC. Caffeinated beverages and decreased seizure control. Seizure. 2003;12:519-521. crossref(new window)

Kerr BM, Thummel KE, Wurden CJ, Klein SM, Kroetz DL, Gonzalez FJ, Levy RH. Human liver carbamazepine metabolism Role of CYP3A4 and CYP2C8 in 10, 11-epoxide formation. Biochem Pharmacol. 1994;47:1969-1979. crossref(new window)

Keyser A, De Bruijn SF. Epileptic manifestations and vitamin B1 deficiency. Eur Neurol. 1991;31:121-125. crossref(new window)

Kim H, Yoon YJ, Shon JH, Cha IJ, Shin JG, Liu KH. Inhibitory effects of fruit juices on CYP3A activity. Drug Metab Dispos. 2006;34:521-523. crossref(new window)

Kossoff EH, Krauss GL, McGrogan JR, Freeman JM. Efficacy of the Atkins diet as therapy for intractable epilepsy. Neurology. 2003;61:1789-1791. crossref(new window)

Krause KH, Berlit P, Bonjour JP. Impaired biotin status in anticonvulsant therapy. Ann Neurol. 1982;12:485-486. crossref(new window)

Kroll JS. Pyridoxine for neonatal seizures: an unexpected danger. Dev Med Child Neurol. 1985;27:377-379.

Kumandas S, Koklu E, Gumus H, Koklu S, Kurtoglu S, Karakukcu M, Keskin M. Effect of carbamezapine and valproic acid on bone mineral density, IGF-I and IGFBP-3. J Pediatr Endocrinol Metab. 2006;19:529-534.

Kuo MF, Wang HS. Pyridoxal phosphate-responsive epilepsy with resistance to pyridoxine. Pediatr Neurol. 2002;26:146-147. crossref(new window)

Labate A, Gambardella A, Messina D, Tammaro S, Le Piane E, Pirritano D, Cosco C, Doldo P, Mazzei R, Oliveri RL, Bosco D, Zappia M, Valentino P, Aguglia U, Quattrone A. Silent celiac disease in patients with childhood localization-related epilepsies. Epilepsia. 2001;42:1153-1155.

Lauritzen I, Blondeau N, Heurteaux C, Widmann C, Romey G, Lazdunski M. Polyunsaturated fatty acids are potent neuroprotectors. EMBO J. 2000;19:1784-1793. crossref(new window)

Levy. SL, Burnharn WM, Hwang PA. An evaluation of the anticonvulsant effects of vitamin E. Epilepsy Res. 1990;6:12-17. crossref(new window)

Mantovani J, De Vivo DC. Effects of taurine on seizures and growth hormone release in epileptic patients. Arch Neurol. 1979;36:672-674. crossref(new window)

Mattson RH, Gallagher BB, Reynolds EH, Glass D. Folate therapy in epilepsy. A controlled study. Arch Neurol. 1973;29:78-81. crossref(new window)

Mikati MA, Trevathan E, Krishnamoorthy KS, Lombroso CT. Pyridoxine-dependent epilepsy: EEG investigations and longterm follow-up. Electroencephalogr Clin Neurophysiol. 1991;78:215-221. crossref(new window)

Mintzer S, Boppana P, Toguri J, DeSantis A. Vitamin D levels and bone turnover in epilepsy patients taking carbamazepine or oxcarbazepine. Epilepsia. 2006;47:510-515. crossref(new window)

Miwa H, Iijima M, Tanaka S, Mizuno Y. Generalized convulsions after consuming a large amount of Gingko nuts. Epilepsia.2001;42:280-281.

Mock DM, Dyken ME. Biotin catabolism is accelerated in adults receiving long-term therapy with anticonvulsants. Neurology..1997;49:1444-1447. crossref(new window)

Mock DM, Mock NI, Nelson RP, Lombard KA. Disturbances in biotin metabolism in children undergoing long-term anticonvulsant therapy. J Pediatr Gastroenterol Nutr. 1998;26:245-250. crossref(new window)

Monaco F, Mutani R, Durelli L, Delsedime M. Free amino acids in serum of patients with epilepsy: significant increase in taurine. Epilepsia. 1975;16:245-249. crossref(new window)

Monami M, Mannucci E, Breschi A, Marchionni N. Seizures as the only clinical manifestation of reactive hypoglycemia: a case report. J Endocrinol Invest. 2005;28:940-941. crossref(new window)